Quick take:
- Low-dose ketamine infusions are administered under medical supervision to address treatment-resistant depression and certain chronic pain conditions.
- Clinical research shows measurable improvement in some patients, though findings on chronic pain remain mixed across studies.
- Sessions are typically delivered in a series over several weeks, with monitoring for safety and response.
Ketamine therapy refers to the medically supervised use of low, sub-anesthetic doses of ketamine, usually given by IV infusion, to treat conditions such as treatment-resistant depression, anxiety, and some forms of chronic pain. It differs from the anesthetic doses used in surgery and is administered in controlled clinical settings with monitoring throughout each session.
For residents researching ketamine therapy in Grand Rapids, MI, understanding how the treatment works, what the research says, and what a session actually involves can help set realistic expectations before scheduling a consultation. This is a clinical intervention, not a quick fix, and it works best as part of a broader care plan that may include psychotherapy or ongoing pain management.
How Ketamine Therapy Works
Ketamine acts on glutamate receptors in the brain rather than the serotonin pathways targeted by traditional antidepressants, which is part of why it can produce effects more quickly in some patients. Researchers note that it primarily targets glutamatergic neurons within cortical and limbic circuits, alleviating central sensitization linked to chronic pain while enhancing connectivity that contributes to depression relief.
A typical course involves several steps:
- Medical history review and screening for eligibility.
- A series of IV infusions scheduled over multiple weeks rather than a single visit.
- Monitoring during each session for blood pressure, heart rate, and psychological response.
- Follow-up evaluation to track symptom changes over time.
Because ketamine’s approved use is limited, it’s worth noting that ketamine is only FDA-approved for depression and anesthesia, so its use in treating pain is considered off-label. The FDA’s information on esketamine outlines the one ketamine-derived product cleared specifically for depression, which helps clarify where the broader off-label use of IV ketamine fits into current practice.
What the Research Shows for Depression and Pain
Evidence on ketamine’s effectiveness is evolving and, in some areas, still contested. A 2025 Cleveland Clinic study found that the ketamine protocol, delivered within a comprehensive clinical pain program, helped 20% to 46% of patients achieve meaningful improvements in their daily functioning, sleep, and pain management. That same research reported improvements in pain interference, depression, and physical function lasting up to six months, with nearly half of patients showing clinically meaningful improvement in pain-related anxiety.
At the same time, a 2025 Cochrane review raised caution. Researchers who examined dozens of trials found that the off-label use of ketamine to treat chronic pain is not supported by scientific evidence, and the review identified no clear evidence of benefit for ketamine in chronic pain and identified an increased risk of adverse effects such as delusions, delirium, paranoia, nausea, and vomiting.
| Research Source | Year | Key Finding |
| Cleveland Clinic (Regional Anesthesia & Pain Medicine) | 2025 | Meaningful functional and pain improvement in a subset of patients |
| Cochrane Review (UNSW Sydney, NeuRA, Brunel University) | 2025 | No clear evidence of pain benefit; adverse effects noted |
| Frontiers in Pain Research case series | 2025 | Combined ketamine and biopsychosocial therapy aided select patients |
This mixed picture underscores why ketamine therapy is generally positioned as one option among several, not a guaranteed solution, and why patient selection and monitoring matter.
What to Expect Before Starting Treatment
Anyone considering this option in Grand Rapids, MI should expect an initial clinical screening before any infusion is scheduled. Providers typically review:
- Current medications and prior treatment history
- Cardiovascular health and blood pressure stability
- Mental health diagnosis and symptom severity
- Any history of substance use concerns
Sessions are usually conducted in a quiet, monitored setting, with vital signs checked throughout. Recovery time after each infusion is generally short, though patients are advised not to drive immediately afterward.
Frequently Asked Questions
Is ketamine therapy the same as using ketamine recreationally? No. Clinical ketamine therapy uses carefully measured, sub-anesthetic doses administered under medical supervision, with dosing and monitoring that differ substantially from recreational use.
How many sessions are typically needed? Protocols vary by provider and patient, but infusions are commonly scheduled as a series over a few weeks rather than as a single treatment.
Does ketamine therapy replace other depression or pain treatments? It is generally used alongside, not instead of, other care such as psychotherapy, medication management, or pain rehabilitation programs.
Are there risks to be aware of? Yes. Reported effects can include temporary dissociation, nausea, or changes in blood pressure during infusion, which is why monitoring is a standard part of treatment.
Based in USA, BioFuse serves patients across Grand Rapids, MI who are researching clinically supervised infusion programs. A business profile listing BioFuse includes details on the services available to the area.
Learning More
Published scheduling and provider details for BioFuse are available for those reviewing options in the region.
